Lauri Kareinen

13PUBLICATIONS
56CO-AUTHORS
Agricultural molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Biomolecular modelling and designCardiology (incl. cardiovascular diseases)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 11, 2026
Inhibition of host N-myristoylation compromises the infectivity of SARS-CoV-2 due to Golgi-bypassing egress.

|Apr 03, 2024
Ancestral allele of DNA polymerase gamma modifies antiviral tolerance.

Yilin Kang, Jussi Hepojoki, Rocio Sartori Maldonado

|Feb 16, 2024
Nanobody engineering for SARS-CoV-2 neutralization and detection.

Liina Hannula, Suvi Kuivanen, Jonathan Lasham

|Jul 27, 2022
Clinical and Serological Findings of COVID-19 Participants in the Region of Makkah, Saudi Arabia.

Othman R Alzahrani, Abdullah D Alanazi, Lauri Kareinen

|Apr 12, 2022
Inhibition of SARS-CoV-2 Alpha Variant and Murine Noroviruses on Copper-Silver Nanocomposite Surfaces.

Dina A Mosselhy, Lauri Kareinen, Ilkka Kivistö

|Dec 13, 2021
Carboxypeptidase A3 expression in canine mast cell tumors and tissue-resident mast cells.

Sanna Hämäläinen, Lauri Kareinen, Antti Sukura

Pageof 3

Frequent Collaborators

7 joint publications

Jussi Hepojoki

5 joint publications

Olli Vapalahti

5 joint publications

Tarja Sironen

3 joint publications

Ravi Kant